Skip Navigation

Department of Microbiology and Immunology

Steve Tomlinson, PhD

Tomlinson PictureProfessor and Vice Chair for Research & Faculty Development
Microbiology & Immunology

1990-1991  Postdoctoral Fellow, Dept. of Molecular Biology, University of Florida at Gainesville

1989  Ph.D., University of Cambridge, UK

Contact Info
Tel: 843-792-1450
CRI 213

Research Interests

Complement is a group of over 30 soluble and cell surface proteins that represent a crucial component of both the innate and adaptive immune systems. Research in the laboratory is focused on the biology of the complement system, and how it modulates an inflammatory response and shapes adaptive immunity. Within the context of complement-modulated immunity, areas of study relate to ischemic injury and disease (such as stroke, spinal cord injury and post-transplant ischemia reperfusion injury), alloimmunity (transplant rejection) and cancer immunity. A further area of study is the dual role of complement in liver injury and regeneration, important in the context of liver resection or small-for-size transplant. Integrated within these studies is the development and characterization of various site-targeted strategies for complement inhibition. These strategies (some of which are in clinical development) are being investigated in various mouse models of injury and disease. 

Publications (selected from 126) | Additional Publications

He S, Atkinson C, Qiao F, Cianflone K, Chen X, and Tomlinson S. (2009) A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration, and clinical implications. J. Clin. Invest. 119:2304-16.

Atkinson C, Mosely E, Varela JC, Stoica S, Large S, Goddard M, and Tomlinson S. (2009) Complement dependent inflammation and Injury in a murine model of brain dead donor hearts. Circ. Research 105:1094-1101. PMCID: PMC2783176

Khan MA, Jiang X, Beilke J, Holers VM, Atkinson C, Tomlinson S, and Nicolls M. (2011) CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants. Circ. Research 109:1290-301.

Takeda K, Thurman JM, Tomlinson S, Okamato M, Shiraishi Y, Ferreira VP, Cortez C, Pangburn MK, Holers VM, and Gelfand EW. (2012). The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness (AHR) and inflammation. J. Immunol. 188: 661-7.

Elvington A, Atkinson C, Kulik L, Zhu H, Yu J, Kindy MS, Holers VM, and Tomlinson S. (2012) Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J. Immunol. 188:14660-8.

Schepp-Berglind J, Atkinson C, Elvington M, Qiao F, Mannon P, and Tomlinson S. (2012) Complement-dependent injury and protection in a murine model of acute DSS-induced colitis. J. Immunol. 188:6309-18.

Elvington M, Huang Y, Morgan BP, Qiao F, van Rooijen N, Atkinson C, and Tomlinson S. (2012) A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer. Blood 119:6043-51.

Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S. (2012). The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J. Immunol. 189:4640-7.

Holers VM, Rohrer B, and Tomlinson S. (2013). CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation. Adv. Exp. Med. Biol. 734:137-54.

Kahn MA, Maasch C, Vater A, Klussmann S, Morser J, Leung LL, Atkinson C, Tomlinson S, Heeger PS, and Nicolls MR. (2013). Targeting C5a promotes vascular integrity and limits airway remodeling. Proc. Nat. Acad. Sci. 110:6061-6.

Atkinson C, Floerchinger B, Qiao F, Casey S, Williamson T, Mosely E, Stoica S, Goddard M, Ge X, Tullius SG, and Tomlinson S. (2013). Donor brain death exacerbates complement-dependent ischemia reperfusion injury in transplanted hearts. Circulation 127:1290-9.

Elvington M, Blichmann P, Qiao F, Scheiber M, Wadsworth C, Luzinov I, Lucero J, Vertegel A, and Tomlinson S. (2014) A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis. Clin. Exp. Immunol. 177:500-8.

Elvington M, Scheiber M, Yang X, Lyons K, Jacqmin D, Wadsworth C, Marshall D, Vanek K, and Tomlinson S. (2014) Complement dependent modulation of anti-tumor immunity following radiation therapy. Cell Reports 8:818-30.

Marshall KM, He S, Zhong Z, Atkinson C, and Tomlinson S. (2014) Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. J. Exp. Med. 211:1793-1805.

Research Support

Title: Complement, anti-tumor immunity and apoptosis-based therapy
Agency: NIH/NCI
Role: PI
Funding Period: 1/1/12-12/31/17

Title: The complement system and spinal cord injury
Agency: Dept. Veteran’s Affairs
Role: PI
Funding Period: 11/15/11-11/14/15

Title: Role of complement in brain death induced injury to donor hearts
Agency: NIH/NHLB
Role: PI
Funding Period: 8/1/07-7/31/12

Title: Role of complement in inflammatory bowel disease
Agency: Crohn’s and Colitis Foundation of America
Role: PI
Funding Period: 1/7/10-06/30/13

Title: Complement and cognitive recovery after stroke
Agency: Alexion Pharmaceuticals
Role: PI
Funding Period: 9/1/12-8/31/14

Title: The role of complement in the pathogenesis of emphysema
Agency: NIH/NHLB
Role: Co-I
Funding Period: 3/1/10-2/28/15

Title: Alternative Pathway of Complement Activation in Age-Related Macular Degeneration
Agency: NIH/NEI
Role: Co-I
Funding Period: 7/01/10-6/30/15

Title: Therapeutic intervention in traumatic brain injury
Agency: Dept. Veteran’s Affairs
Role: Co-I
Funding Period: 6/1/10-5/31/13

top of page


© 2012  Medical University of South Carolina | Disclaimer